Conference Coverage

New agent builds bone bigger, faster

Publish date: July 17, 2014

 

AT ICE/ENDO 2014

References

These phase II studies were funded by Radius Health.

bjancin@frontlinemedcom.com

Pages

Recommended Reading

No survival benefit to bisphosphonate in chemoresistant breast cancer
MDedge ObGyn
Romosozumab boosts bone density while cutting resorption
MDedge ObGyn
USPSTF: Insufficient evidence to judge vitamin supplements
MDedge ObGyn
It’s time to put to rest the calcium supplement controversy
MDedge ObGyn
Yearly monitoring does not predict fractures after bisphosphonate cessation
MDedge ObGyn
Nonmelanoma skin cancer linked to increased fracture risk in postmenopausal women
MDedge ObGyn
VIDEO: Less frequent zoledronic acid is safe, retains efficacy
MDedge ObGyn
Denosumab's benefits persist through 8 years
MDedge ObGyn
Monitor elderly for bone loss after gastric bypass
MDedge ObGyn
Monitor elderly for bone loss after gastric bypass
MDedge ObGyn